Hand-Assisted Laparoscopic Nephroureterectomy for Upper Urinary Tract Transitional Cell Carcinoma by Raman, Jay D. et al.
Hand-Assisted Laparoscopic Nephroureterectomy for
Upper Urinary Tract Transitional Cell Carcinoma
Jay D. Raman, MD, Michael A. Palese, MD, Casey K. Ng, MD, Stephen A. Boorjian, MD,
Douglas S. Scherr, MD, Joseph J. Del Pizzo, MD, R. Ernest Sosa, MD
ABSTRACT
Objective: We report our experience with hand-assisted
laparoscopic nephroureterectomy (HALN) for upper uri-
nary tract transitional cell carcinoma and compare our
results with a contemporary series of open nephroureter-
ectomy (ON) performed at our institution.
Methods: Between August 1996 and May 2003, 90 pa-
tients underwent nephroureterectomy for upper-tract
transitional cell carcinoma (TCC). Thirty-eight patients un-
derwent HALN, while 52 had an ON. End-points of com-
parison included operative time, estimated blood loss
(EBL), intraoperative and postoperative complications,
length of hospital stay, pathologic grade and stage of
tumor, and tumor recurrence.
Results: The mean patient age was 72.3 and 70.6 years in
the ON and HALN groups, respectively. Mean operative
duration was 243 minutes (ON) and 244 minutes (HALN),
with an EBL of 478mL in the open group versus 191mL in
the hand-assisted group (P0.001). No intraoperative
complications occurred, but postoperative complications
occurred in 4% and 11% of the ON and HALN groups,
respectively (P0.21). The mean hospital duration was
7.1 days (ON) versus 4.6 days (HALN) (P0.01). No dif-
ference existed in the pathologic grade or stage distribu-
tion of urothelial tumors between the 2 groups. The mean
follow-up was 51.0 months in the ON group and 31.7
months in the HALN group. Recurrence of urothelial car-
cinoma occurred in 50% of patients who underwent ON
and 40% treated by HALN (P0.38) at a median interval of
9.1 and 7.7 months, respectively, after surgery.
Conclusion: Hand-assisted laparoscopic nephroureterec-
tomy is an effective modality for the treatment of upper
urinary tract urothelial carcinoma. Patients benefited from
less intraoperative blood loss and a shorter hospitalization
with an equivalent intermediate-term oncologic outcome
compared with that of the open approach.
Key Words: Transitional cell carcinoma (TCC),
Nephroureterectomy, Hand-assisted laparoscopy, Uro-
logic oncology.
INTRODUCTION
Transitional cell carcinoma (TCC) of the upper urinary
tract (UUT) represents approximately 5% of urothelial
malignancies and less than 10% of all renal tumors.1 Al-
though open radical nephroureterectomy with excision of
an ipsilateral periureteral bladder cuff has been consid-
ered the standard management for upper tract TCC,2 the
operation is associated with a lengthy hospitalization and
convalescence. The morbidity associated with the open
approach has led to the investigation of minimally inva-
sive techniques that may serve as alternatives.
Antegrade and retrograde endoscopic management of up-
per-tract TCC have been reported for treatment of this
disease.3,4 However, the indications for these approaches
are highly select and should be reserved for patients with
a solitary kidney, renal insufficiency, bilateral disease, or
low-volume tumors. The introduction of the laparoscopic
nephroureterectomy, first performed in 1991 at Washing-
ton University,5 has provided another minimally invasive
alternative to open surgery. Compared with open
nephroureterectomy, early results with the laparoscopic
approach were encouraging with decreased postoperative
analgesia requirements, shorter hospitalization, better cos-
mesis, and improved convalescence.6 Despite these pa-
tient advantages, drawbacks of the laparoscopic approach
include the lengthy operative time, the steep learning
curve, and the need for a skilled laparoscopic surgeon.
The hand-assisted transperitoneal laparoscopic approach
has been part of the evolution in minimally invasive al-
ternatives for patients with upper-tract TCC. Keeley and
colleagues7 reported the initial results with this approach
and noted a significantly shorter operative duration than
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SCIENTIFIC PAPERtheir series of laparoscopic nephroureterectomy. Several
other small series have subsequently demonstrated the
safety and efficacy of this procedure with comparable
short-term oncologic control.8,9
To date, 38 patients with upper-tract transitional cell car-
cinoma have been treated with a hand-assisted transperi-
toneal laparoscopic nephroureterectomy (HALN) at our
institution. We report our single institution experience
and compare our outcomes data with that of a contem-
porary series of 52 consecutive patients who underwent
an open radical nephroureterectomy (ON).
METHODS
Patient Selection
We retrospectively reviewed the records of 90 consecutive
patients who underwent an open (ON) or hand-assisted
laparoscopic transperitoneal (HALN) radical nephroure-
terectomy between August 1996 and May 2003 at the New
York-Presbyterian Hospital. Thirty-eight patients under-
went HALN, while 52 had an ON. All laparoscopic proce-
dures were performed by 1 of 2 surgeons (JDP and RES),
while various surgeons were involved in the open proce-
dures.
Diagnosis of upper-tract transitional cell carcinoma was
established by computed tomography, excretory urogram,
retrograde ureteropyelogram, and/or ureteroscopy with
tissue biopsies. Postoperative follow-up comprised regu-
lar interval history and physical examination, urinary cy-
tologies, chest x-rays, and abdominopelvic CT scan. Sur-
veillance cystoscopy was performed every 3 months for 2
years and every 6 months for the next 2 years. Demo-
graphic, operative, and follow-up data were recorded and
compared between the 2 groups.
Demographic information of these 90 patients is
summarized in Table 1.
Operative Technique
Patients in each group underwent a bowel preparation
with a clear liquid diet and a bottle of magnesium citrate.
Perioperative antibiotics were infused in the operating
room, and general anesthesia with endotracheal intuba-
tion was used in all cases. An oral gastric tube was used to
decompress the stomach, and venous insufflation boots
were used to prevent lower extremity stasis.
Hand-Assisted Laparoscopic Nephroureterectomy
(HALN)
The patient was placed in the flank position with ade-
quate padding for the brachial plexus and the dependent
hip, knees, and ankles. The lower leg was flexed while the
upper leg was gently extended and a pillow placed be-
tween them. The operating table was flexed and the
kidney rest was raised.
For right-sided HALN, 4 ports were utilized: a 12-mm
trocar at the midclavicular line 2cm below the umbilicus
(working instrument), a 5-mm periumbilical trocar (work-
ing instrument), a 5-mm trocar at the midline 5-cm above
the umbilicus (camera), and a second 5-mm trocar just
under the costal margin for the liver retractor. A 7-cm right
lower quadrant incision was utilized for the hand-assist
device. Left-sided HALN utilized a 12-mm trocar at the
midclavicular line 2-cm inferior to the umbilicus (working
instrument), a 5-mm trocar adjacent to the umbilicus
(working instrument), a 5-mm trocar at the midline 2
finger breaths below the xyphoid process (camera), and a
Table 1.
Demographic Data
HALN* ON* P Value
No. Patients 38 52 —
Age (range) 71 (43–79) 72 (54–82) 0.87
Sex (M/F) 23/15 26/26 0.32
Mean ASA Class 2.8 2.6 0.07
Presenting sx (%)
Hematuria 31 (82) 37 (71) 0.31
TCC* surveillance
† 6 (16) 13 (25) 0.29
Systemic symptoms 1 (3) 0 (0) 0.24
Incidental 0 (0) 2 (4) 0.22
Location of Tumor
Right/Left 22/16 29/23 0.84
Renal Pelvis 25 (66) 24 (46) 0.06
Upper Ureter 2 (5) 3 (6) 0.92
Mid Ureter 1 (3) 3 (6) 0.48
Lower Ureter 6 (16) 12 (23) 0.39
Multifocal 4 (11) 10 (19) 0.26
*HALNhand-assisted laparoscopic nephroureterectomy; ON
open nephroureterectomy; TCCtransitional cell carcinoma.
†Patients with a history of bladder cancer with surveillance stud-
ies revealing an upper urinary tract lesion.
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(Figure 1).
For the right nephroureterectomy, the right colon and
hepatic flexure were medially mobilized, and the right
lobe of the liver was released from the body wall. The
coronary ligament was incised to expose the upper pole
of the kidney and the inferior vena cava. The duodenum
was mobilized medially with the Kocher maneuver for
exposure of the renal hilum. The renal hilum was then
adequately dissected for identification of the renal artery
and vein. The artery and then the renal vein were divided
using the Endo-GIA vascular stapler. The remaining at-
tachments of the kidney were then dissected from sur-
rounding tissues with the Harmonic scalpel. Gerota’s fas-
cia was kept intact and the adrenal gland was left in place.
For left-sided nephroureterectomy, the colon was medial-
ized from the level of the iliac vessels to the splenic
flexure. The lateral splenic attachments were freed to the
level of the gastric fundus. The colon, spleen, and pan-
creas were mobilized en bloc resulting in exposure of the
anterior aspect of Gerota’s fascia. In a similar fashion to
the right, the hilum was exposed, the artery and then the
vein were isolated and divided, and the kidney with Gero-
ta’s fascia intact was separated from the adrenal gland.
Management of the Distal Ureter and Bladder Cuff
The ureter was dissected to the level of the bladder by a
combination of blunt dissection, clips, and electrocautery.
The intramural ureter was managed by several different
modalities as previously described.10 These techniques
are briefly discussed below.
The open extravesical technique involves applying clips
across the distal ureter to prevent tumor spillage during
manipulation of the specimen. The hand-assist device is
replaced by a self-retaining retractor, and traction is used
to facilitate dissection of the transmural ureter. The detru-
sor muscle is then opened circumferentially from outside
the bladder, and a 2-cm cuff of bladder with mucosa is
removed en bloc with the distal ureter. The opening in the
bladder is closed in 2 layers with 2–0 and 3–0 absorbable
sutures.
The open intravesical technique was used in patients with
evidence of distal ureteral malignancy. Surgical exposure
of the bladder was obtained either through the hand-assist
device incision, Pfannensteil, or Gibson incision. An an-
terior cystotomy was made and the ipsilateral ureteral
orifice was circumferentially excised with traction placed
on the extravesical ureter. Two centimeters of bladder cuff
was removed, and these defects, as well as the anterior
cystotomy, were closed in 2 layers with absorbable su-
tures.
In the cystoscopic technique, the ureter was completely
Figure 1. Trocar configuration and hand-assist device place-
ment for (A) right and (B) left hand-assisted laparoscopic
nephroureterectomy
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endoscopic stapling device was used to transect the distal
ureter across the detrusor muscle. The patient was then
repositioned in the dorsal lithotomy position. The ipsilat-
eral ureteral orifice was unroofed with a Collins knife
attached to a resectoscope on cutting current. The incision
was carried through the detrusor wall until extravesical
fat, and the staple line were cauterized. A Foley catheter
was left in place for a minimum of 7 days with the defect
healing primarily.
Open Nephroureterectomy (ON)
The open surgical approach used an extraperitoneal flank
approach to remove the kidney and the upper ureter. The
distal ureter was excised either through a Pfannenstiel or
a Gibson incision with similar management of the intra-
mural ureter as described above.
Outcomes
End-points of comparison included operative duration,
estimated blood loss (EBL), intraoperative and postoper-
ative complications, length of hospital stay, pathologic
grade and stage of tumor, and tumor recurrence. Statistical
analysis was performed using the unpaired, 2-tailed Stu-
dent t test and the chi-square (
2) log-rank test with the
Yates correction factor. The Excel 2000 (Microsoft, Red-
mond, Washington) and SAS for Windows, version 9.1
(SAS Institute, Cary, North Carolina) software programs
were used for statistical calculations.
RESULTS
Table 1 shows the demographics of patients in the 2
operative groups. No significant difference existed be-
tween the hand-assisted laparoscopic and open surgical
groups with respect to patient age, gender distribution,
preoperative American Society of Anesthesiology (ASA)
score, presenting symptoms, or tumor location. There was
also no difference between the number of left-sided and
right-sided surgical procedures performed between the
groups.
Operative and Postoperative Outcomes
The hand-assisted laparoscopic group benefited from less
blood loss (191 mL vs 478 mL) and a shorter hospital
duration (4.6 vs 7.1 days) with an almost identical mean
operative duration (244 vs 243 minutes) (Table 2).N o
conversions were needed from the hand-assisted ap-
proach to the open surgical approach. Of the hand-as-
sisted group, no intraoperative complications occurred;
however, 4/38 (11%) patients had a postoperative com-
plication. Two patients had postoperative bleeding (one
requiring re-exploration on postoperative day 1 without
identification of a distinct source), one patient developed
an enterocutaneous fistula that was managed conserva-
tively by parenteral nutrition, and another patient had a
myocardial infarction that required cardiac catheterization
and angioplasty with coronary stenting. No mortalities
occurred in this group. The open surgical group also had
no intraoperative complications, but 2 patients had com-
plications postoperatively. One patient developed an oc-
cipital cerebrovascular infarction requiring postoperative
anticoagulation with no residual deficits at this time, and
the other patient had a postoperative arrhythmia requiring
pacemaker placement. There was no significant difference
in the complication rate between the hand-assisted and
open surgical groups (11% vs 4%, P0.65).
Oncologic Outcomes
Pathologic evaluation confirmed that all tumors were tran-
sitional cell carcinoma. There was no difference in the
pathologic grade and stage distribution of tumors be-
tween the 2 surgical groups (Table 3). The mean fol-
Table 2.
Comparison of Hand-Assisted Laparoscopic
Nephroureterectomy and Open Nephroureterectomy Operative
and Postoperative Data
HALN* ON* P Value
Operative Duration
(min) (range)
244 (90–50) 243 (50–400) 0.91
Estimated Blood Loss
(mL) (range) 191 (25–475) 478 (100–2200) 0.001
Complications (%)
Intraoperative 0 (0) 0 (0)




cuff 22 (58) 32 (55) 0.79
Intravesical bladder
cuff 8 (21) 20 (34) 0.08
TUR* unroofing of
ureteral orifice 8 (21) 0 (0) 0.001
Hospital Days (range) 4.6 (2–8) 7.1 (4–13) 0.01
*HALNhand-assisted laparoscopic nephroureterectomy; ON
open nephroureterectomy; TURtransurethral resection.
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vs 51.0 months) than the ON group. This was expected as
the HALN was first performed at our institution in 1999,
and our series reflects the evolution of the laparoscopic
experience since that time. At a mean follow-up of 31.7
months and 51.0 months, respectively, 58% (22/38) of the
HALN and 44% (23/52) of the ON group had no evidence
of disease recurrence.
In the HALN group, the overall recurrence rate of TCC in
our series was 40% (15 of 38 patients) at a mean interval
of 7.7 months after surgery. Of the 15 recurrences, 11
occurred in the bladder. Eight of these 11 patients had a
history of transitional cell carcinoma of the bladder that
was present before the diagnosis of upper-tract disease. In
considering the management of the distal ureter, no dif-
ference was noted in bladder recurrences based on
whether the technique was extravesical,6 intravesical,2 or
cystoscopic3 (P0.65). Also no recurrences were noted at
the port sites, incision sites, or in the location of the
resected distal ureter. Metastasis to the liver developed in
2 patients. The ON group had a 50% overall recurrence
rate (26 of 52 patients) at a mean interval of 9.1 months
after surgery. Eighteen of these recurrences were in the
bladder, and 10 of these patients had a prior history of
bladder TCC. Once again, the management of the distal
ureter had no bearing on the bladder tumor recurrence
rate. Metastasis to the liver occurred in one patient.
DISCUSSION
Historically, the standard management of upper urinary
tract transitional cell carcinoma has been open nephroure-
terectomy with excision of an ipsilateral bladder cuff.
Usually, a single large incision or 2 incisions in the flank
and abdomen are utilized. The morbidity, prolonged pa-
tient convalescence, and duration of hospitalization have
been documented and are significant. The introduction of
laparoscopic techniques was developed to reduce the
morbidity of the procedure while maintaining the basic
principles of surgical oncology.
Multiple series have documented that laparoscopic rad-
ical nephroureterectomy has helped improve patient
convalescence and decrease hospitalization when com-
pared with the open surgical approach.6,11 However,
the procedure is technically difficult and is associated
with a steep learning curve. We feel that the hand-
assisted approach offers several advantages over the
pure laparoscopic approach. Firstly, it allows the less
experienced urologist a more feasible alternative to
nephroureterectomy than open surgery. Having a hand
in the operative field allows for tactile sensation, spatial
orientation, and blunt dissection, which are currently
limited using the standard laparoscopic technique. It
may be the most reasonable alternative to open surgery
for urologists not facile with pure laparoscopic surgery.
The other advantage is the ability to remove the spec-
imen intact without requiring tissue morcellation. In a
comparison of hand-assisted and standard laparoscopic
nephroureterectomy, Landman and colleagues found
that HALN decreased operative times without altering
short-term measures of convalescence compared with
standard laparoscopy.12
To date, several series have noted the effectiveness of
transperitoneal hand-assisted laparoscopic surgery for
managing upper-tract TCC. In a prospective, nonran-
domized study, Seifman and colleagues noted a longer
operative duration, but shorter hospitalization, with
Table 3.
Pathologic and Follow-up Data
HALN* ON* P Value
Mean Follow-up mos
(range) 31.7 (8–47) 51.0 (13–135) 0.05
Pathologic Grade (%)
Low (I and II) 23 (60) 33 (63) 0.78
High (III) 15 (40) 19 (37)
Pathologic Stage (%)
Superficial
(TaTisT1) 27 (71) 41 (79) 0.67
Invasive (T2T3T4) 9 (29) 11 (21)
Mean Interval to
Recurrence (mos) 7.7 9.1 0.55
Recurrence of TCC* (%)
Bladder 11 (29) 18 (35) 0.32
Contralateral ureter 1 (3) 2 (4)
Urethra 1 (3) 0 (0)
Metastatic 2 (6) 6 (11)
Current Disease Status*
NED 22 (58) 23 (44) 0.78
AWD 14 (37) 17 (33) 0.69
DOD 1 (3) 9 (17) 0.03
DWOD 1 (3) 3 (6) 0.51
*HALNhand-assisted laparoscopic nephroureterectomy; ON
open nephroureterectomy; TCCtransitional cell carcinoma;
NEDno evidence of disease; AWDalive with disease;
DODdead of disease; DWODdead without disease.
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when comparing hand-assisted laparoscopic to open
nephroureterectomy.13 Several other groups have pro-
vided similar data reflecting these variables.8,9,14,15 Our
series is the largest to date with the longest follow-up
that has compared the transperitoneal hand-assisted
laparoscopic approach to the open approach for
nephroureterectomy. We found that while there was a
comparable operative duration between the 2 proce-
dures, the hand-assisted group benefiting from less
blood loss (191 mL vs 478 mL) and shorter hospital
duration (4.6 vs 7.1 days). No differences existed in the
intraoperative or postoperative complication rates be-
tween the groups, and no patients had positive surgical
margins. From an oncologic perspective, almost 60% of
patients treated by HALN had no evidence of disease at
a mean follow-up of 2.5 years. The majority of TCC
recurrences occurred in the bladder, thus reflecting the
field change effect in the urothelium. Given the high
intravesical recurrence rate in our series, it is imperative
that these patients have close surveillance following
management of the primary upper-tract TCC. When
comparing the HALN and ON groups, no significant
difference was found in either the TCC recurrence rate
(40% vs 50%) or the interval to recurrence (7.7 vs 9.1
months). The higher recurrence rate and mortality rate
in the ON group is most likely a function of the longer
follow-up in this patient cohort. In fact, actuarial dis-
ease specific survivals show a similar 5-year disease
specific survival (81% HALN vs. 77% ON, P0.81) be-
tween the 2 surgical groups (data not shown).
The commonly reported techniques for treating the
distal ureter and bladder cuff include extravesical exci-
sion with bladder cuff, intravesical excision with blad-
der cuff, and cystoscopic unroofing of the intramural
tunnel with extravesical excision of the distal ureter.10
The hand-assisted approach affords a significant advan-
tage in that the surgeon can facilitate dissection and
resection by providing gentle countertraction on the
distal ureter. Our series noted no differences in TCC
recurrence rates based on the management of the distal
ureter. Of note, it is difficult to specifically compare
each technique for management of the distal ureter
given the propensity for development of bladder tu-
mors in 30% to 50% of patients with negative margins
following nephroureterectomy. Furthermore, the small
number of patients in each subgroup of distal ureteral
management makes it difficult to draw significant con-
clusions between efficacy of one technique versus an-
other. In our experience, the extravesical ureteral exci-
sion through the original hand-assist port was the most
time efficient approach as it avoided repositioning the
patient or making a new incision. For distal ureteral
tumors, however, we still prefer the intravesical ap-
proach to optimally visualize that a negative bladder
cuff margin is obtained.
Arguments against the transperitoneal approach include
the potential for intraperitoneal seeding of cancer cells,
manipulation of bowel yielding a prolonged ileus, as well
as the potential for an intraperitoneal urinoma or se-
roma.16 In our series of patients, no recurrences occurred
in the peritoneal cavity, and there was no delay in the
return of bowel function compared with that in a series
performed with a retroperitoneoscopic approach. We ac-
knowledge several limitations in this manuscript including
the heterogeneity of surgeons performing the ON proce-
dure, the limited cohort size in the HALN group, and the
difference in follow-up interval between the 2 surgical
groups. Clearly, as the HALN approach becomes increas-
ingly performed, larger cohorts and longer-term follow-up
will be available for comparison.
CONCLUSION
Hand-assisted laparoscopic transperitoneal radical
nephroureterectomy is an effective surgical option for the
management of upper urinary tract transitional cell carci-
noma. Compared with open nephroureterectomy, pa-
tients benefited from less intraoperative blood loss and a
shorter hospitalization with similar operative duration and
intermediate-term cancer control. HALN successfully du-
plicates the open approach.
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